Novo Nordisk A/S ADR buy StockNews.com
Start price
22.03.25
/
50%
€71.80
Target price
22.03.26
-
Performance (%)
-29.81%
Price
18:27
€49.30
Summary
This prediction is currently active. The prediction for Novo Nordisk A/S ADR disappoints with a performance of -29.81%. Dividends of €1.10 are taken into consideration when calculating the performance. This prediction currently runs until 22.03.26. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Novo Nordisk A/S ADR | -0.617% | -0.617% |
| iShares Core DAX® | -1.740% | -0.402% |
| iShares Nasdaq 100 | -0.157% | -1.714% |
| iShares Nikkei 225® | -1.705% | 3.747% |
| iShares S&P 500 | 0.148% | -0.482% |
Comments by StockNews_com for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S (NYSE: NVO) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Ratings data for NVO provided by MarketBeat